Chongqing Pharscin Pharmaceutical Co., Ltd.

The company is a national key high-tech enterprise integrating scientific research, production and sales, and a large-scale comprehensive modern pharmaceutical enterprise in China. The company is a comprehensive pharmaceutical enterprise integrating drug R&D, production and sales. The business format covers the pharmaceutical industry, pharmaceutical commerce and pharmaceutical retail. The main products are Baweiqilong granules, Weidimei (aluminum magnesium carbonate tablets), Changsong (polyethylene glycol 4000 dispersion), diarrheal tablets, choleretic softgels, gabbeyl mesylate for injection, omeprazole sodium, tangerine ice tablets, supernatant tablets, Duliang softgels, Liuwei Anshen capsules, Rongtong (sodium ferulate for injection), cilostazol tablets, captopril tablets, water king (spirulina capsules), methanesulfonic acid for injections Pefloxacin, Oldman (terazosin hydrochloride capsules), orlistat capsules. Over the years, the company has successively won many honors such as “National Enterprise Technology Center”, “Healthy China Quality Award”, “China Patent Award”, “2019 China's Top 100 Non-prescription Pharmaceutical Enterprises”, “Pharmaceutical Industry Benchmark Enterprise 70th Anniversary of the Founding of New China”, “National Contract-abiding and Credit-worthy Enterprise”, and “National Intellectual Property Demonstration Enterprise”, and has set up postdoctoral research workstations.